CEO Troy Wilson Buys Another $1.24M of Kura Oncology Stock
KURA sits 67% above its 52-week low of $7.358.
Summary
CEO Troy Wilson bought 100,000 shares of Kura Oncology for $1.24 million in an open-market purchase, his second major buy in a week.
Key Events · Ownership and Investor Activity · KURA
-
CEO Buys $1.24M in Open Market
Troy Wilson purchased 100,000 shares at a weighted average price of $12.39, totaling $1,239,000, on August 24, 2026.
-
Second Major Purchase in a Week
This follows his $1.1 million open-market purchase on August 17, bringing his total recent buying to over $2.3 million.
-
Purchase Near 52-Week High
The stock is trading near its 52-week high of $12.90, and Wilson is buying with real cash rather than exercising options.
-
Post-Transaction Holdings
Wilson now holds 479,194 shares directly and indirectly through trusts, including the One Fish Two Fish Revocable Trust.
Analysis · KURA · Life Sciences
CEO Troy Wilson made a second open-market purchase in a week, buying 100,000 shares for $1.24 million at a weighted average price of $12.39. This follows his $1.1 million purchase on August 17, bringing his total recent buying to over $2.3 million. The stock is trading near its 52-week high, and Wilson is buying with real cash, not exercising options. This is a strong conviction signal from the company's top executive.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KURA was trading at $12.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $7.36 to $12.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.